《肿瘤》杂志稿约
摘要
本刊（中国标准连续出版物号：CN31-1372/R,ISSN1000-7431）是上海市肿瘤研究所和癌基因及相关基因国家重点实验室共同主办的专业学术期刊,于1981年1月创刊,是国内最早报道肿瘤相关领域成果和进展的专业期刊之一。欢迎肿瘤相关领域的科研人员、临床医生和在校师生踊跃投稿。
出处
《肿瘤》
CAS
CSCD
北大核心
2011年第1期91-92,共2页
Tumor
参考文献2
-
1陆舜,陈佳艺,吴向华,程文俊,阎骅,薛蔚,宋正波,虞永峰,黄文华,廖美琳.2009年恶性肿瘤临床治疗新进展[J].肿瘤,2010,30(6):455-466. 被引量：15
-
2(美)J.萨姆布鲁克(JosephSambrook),(美)D.W.拉塞尔(DavidW.Russell)著,黄培堂等.分子克隆实验指南[M]科学出版社,2002.
二级参考文献71
-
1SOCINSKI M A,SCHELL M J,PETERMAN A,et al.Phase Ⅲ trial comparing a defined duration of therapy versus continuous the-rapy followed by second-line therapy in advanced-stage Ⅲb/Ⅳ non-small-cell lung cancer[J].J Clin Oncol,2002,20(5):1335-1343.
-
2PARK J O,KIN S K,AHN J S,et al.Phase Ⅲ trial of two versus four additional cycles in patients who are nonprogressive after two cycles of platinum-based chemotherapy in non-small-cell lung can-cer[J].J Clin Oncol,2007,25(33):5233-5239.
-
3BRODOOWICZ T,KRZAKWSKI M,ZWITTER M,et al.Cisplatin and gemcitabine first-line chemotherapy followed by maintenance gemcitabine or best supportive care in advanced non-small cell lung cancer:a phase Ⅲ trial[J].Lung Cancer,2006,52(2):155-163.
-
4FIDIAS P M,DAKHIL S R,LYSS A P,et al.Phase Ⅲ study of immediate compared with delayed docetaxel after front-line therapy with gemcitabine plus carboplatin in advanced non-small-cell lung cancer[J].J Clin Oncol,2009,27(4):591-598.
-
5SANDLER A,GRAY R,PERRY M C,et al.Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer[J].N Engl J Med,2006,355(24):2542-2550.
-
6CAPPUZZO F,CIULEANU T,STELMAKH L,et al.SATURN:A double-blind,randomized,phase Ⅲ study of maintenance erlotinib versus placebo following nonprogression with first-line platinum-based chemotherapy in patients with advanced NSCLC[J].J Clin Oncol,2009,27(7s):abstr 8001.
-
7BELANI C P,BRODOWICZ T,CIULEANU T,et al.Maintenance pemetrexed (Pem) plus best supportive care (BSC) versus placebo (Plac) plus BSC:a randomized phase Ⅲ study in advanced non-small cell lung cancer (NSCLC)[J].J Clin Oncol,2009,27(15S):abstr 8000.
-
8CIULEANU T,BRODOWICZ T,ZIELINSKI C,et al.Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer:a randomised,double-blind,phase 3 study[J].Lancet,2009,374(9699):1432-1440.
-
9MOK T S,THONGPRASERT S,YANG C H,et al.Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma[J].N Engl J Med,2009,361(10):947-957.
-
10KIM E S,HIRSH V,MOK T,et al.Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST):a randomised phase Ⅲ trial[J].Lancet,2008,372(9652):1809-1818.
共引文献14
-
1周风举,彭晔,王宁,李俊红,谢娜,李竞,王兵,李聪.伊立替康联合卡培他滨一线治疗进展期胃癌临床观察[J].中华肿瘤防治杂志,2011,18(9):710-712. 被引量：5
-
2《肿瘤》杂志稿约[J].肿瘤,2011,31(12).
-
3叶翔赟,陆舜,陈智伟.重组人血管内皮抑制素联合EP方案对小细胞肺癌细胞株NCI-H446的增殖抑制和促细胞凋亡作用[J].肿瘤,2012,32(4):239-243. 被引量：2
-
4刘妍,刘巍.重组人粒细胞刺激因子灵活应用1例[J].药品评价,2012(33):47-48. 被引量：1
-
5刘复州,邱浩,王汝杰,邹传奇,刘栓得,胡旭,沈伟伟,张超,周跃,初同伟.不同前列腺癌细胞对成骨前体细胞增殖和成熟能力的影响[J].肿瘤,2013,33(12):1033-1038.
-
6张建.肺癌化疗相关性口腔黏膜炎治疗中rhg-Csf的应用[J].临床肺科杂志,2014,19(3):563-563. 被引量：4
-
7金伟魏,蒋芳.肿瘤手术中无瘤技术的应用进展[J].中国科技成果,2015,0(6):47-50. 被引量：1
-
8李霞,孙莉.中药辨证维持治疗对晚期原发性肝癌患者生存质量和生存率的影响[J].中国实验方剂学杂志,2015,21(10):207-211. 被引量：17
-
9李冬雷,于洪波,杨雷,于海莲,吕玲玲.吉西他滨联合顺铂二线治疗晚期复发或转移宫颈癌的临床效果分析[J].中国性科学,2017,26(3):34-37. 被引量：2
-
10路静静,成巧梅.恶性肿瘤患者主要照顾者的影响因素及护理干预的研究现状[J].护士进修杂志,2017,32(8):702-705. 被引量：24
-
1《肿瘤》杂志稿约[J].肿瘤,2011,31(6):572-576.
-
2《肿瘤》杂志稿约[J].肿瘤,2011,31(8):778-779.
-
3《肿瘤》杂志稿约[J].肿瘤,2011,31(7):676-680.
-
4《肿瘤》杂志稿约[J].肿瘤,2011,31(11).
-
5《肿瘤》杂志稿约[J].肿瘤,2012,32(7).
-
6《肿瘤》杂志稿约[J].肿瘤,2012,32(2).
-
7《肿瘤》杂志稿约[J].肿瘤,2012,32(12).
-
8《肿瘤》杂志稿约[J].肿瘤,2013,33(1).
-
9《肿瘤》杂志稿约[J].肿瘤,2011,31(10).
-
10《肿瘤》杂志稿约[J].肿瘤,2012,32(5).
